Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
about
Interference of bacterial cell-to-cell communication: a new concept of antimicrobial chemotherapy breaks antibiotic resistanceEffects of natural and chemically synthesized furanones on quorum sensing in Chromobacterium violaceumThe formation of biofilms by Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanismsPseudomonas aeruginosa biofilms in cystic fibrosisResponses of Pseudomonas aeruginosa to antimicrobialsQuorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosaQuercetin Influences Quorum Sensing in Food Borne Bacteria: In-Vitro and In-Silico EvidenceImpact of Azithromycin on the Quorum Sensing-Controlled Proteome of Pseudomonas aeruginosaPA3297 Counteracts Antimicrobial Effects of Azithromycin in Pseudomonas aeruginosa.Activation of ExoU phospholipase activity requires specific C-terminal regions.Tobramycin at subinhibitory concentration inhibits the RhlI/R quorum sensing system in a Pseudomonas aeruginosa environmental isolateQuenching the quorum sensing system: potential antibacterial drug targets.Diffuse panbronchiolitis: role of macrolides in therapy.Azithromycin inhibits the formation of flagellar filaments without suppressing flagellin synthesis in Salmonella enterica serovar typhimuriumMechanisms of action and clinical application of macrolides as immunomodulatory medications.Azithromycin increases survival and reduces lung inflammation in cystic fibrosis miceAbsolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Expression of PPARĪ³ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilmRegional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin.Synergistic effect of 14-alpha-lipoyl andrographolide and various antibiotics on the formation of biofilms and production of exopolysaccharide and pyocyanin by Pseudomonas aeruginosa.Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and RsmZ in Pseudomonas aeruginosaDNA microarrays in analysis of quorum sensing: strengths and limitations.Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infectionsMass Spectrometry Analysis of Pseudomonas aeruginosa Treated with Azithromycin.Autoinducer production and quorum-sensing dependent phenotypes of Pseudomonas aeruginosa vary according to isolation site during colonization of intubated patients.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin.Pathogen-host interactions in Pseudomonas aeruginosa pneumoniaIncreased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infectionAzithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) micePseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosisAzithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.Macrolide antibiotics like azithromycin increase lipopolysaccharide-induced IL-8 production by human gingival fibroblasts.Azithromycin and lower respiratory tract infections.Reducing Virulence and Biofilm of Pseudomonas aeruginosa by Potential Quorum Sensing Inhibitor Carotenoid: Zeaxanthin.Macrolides in cystic fibrosis.Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa.
P2860
Q21131123-E99E2E35-1B0C-4156-8D55-CBBD5DFD5551Q24798034-700998FA-27C8-4461-AA92-9A11954E9CAFQ26849416-532F73F4-6091-4FFC-884E-71BD1CE5FA41Q28299966-06894973-FA5A-4FF8-AF66-8D9CF5803AAEQ28305587-6A4FF4D6-FF87-4535-94F6-F82B343E2C29Q28473858-57DC7A3B-BD92-44A6-93B8-0D63D783AF3CQ28547091-092DD501-C0C7-4005-9DB4-EFA81F507FD6Q28552822-EC597364-410E-451B-95A4-6CC98699CD6BQ29346778-111603E1-697B-49CC-94DA-5E0DD27051C8Q33526200-892B766D-AF45-4C64-BB7E-C8262289F34AQ33594902-9F36F1DF-5C25-4DD9-9C1E-99361749F227Q33805168-CEAF62A6-572F-4A2F-AC32-39BE562D7C8FQ33844388-AAA3C9E3-4AA9-4072-894E-E39C47C4EE0DQ33938208-191C1CC6-6A0C-4504-8E68-3CCB8C991FB6Q33983140-020A381D-4451-4781-999F-2284D77A3B83Q34185975-0048C7EB-2364-42C6-9BB6-4312CFEBEF0BQ34228376-A3E9893F-D89D-4665-A557-0674DCFAA3C4Q34297656-63BDF85F-10A7-4572-A754-3C0D65C1C3A9Q34364700-147B93BD-2C7E-45D6-93AD-48449C6FE24CQ34375192-110CB4F7-8CF9-417A-9B76-83C1039A1231Q34408724-572A8E5A-24B2-42CD-836A-0AFF07B95304Q34533624-91FD36D9-A9A2-4183-B46A-B6B19FD92B73Q35004860-89478F19-8D4A-4383-BDF3-3959CA92568AQ35065762-28F3A10B-3EB4-42B6-A0D9-D350254D9AE0Q35088116-F757012D-248E-4BE6-9D6E-C509B858B19CQ35575533-46772AB3-9988-4E14-A47A-51B2AE0B23E0Q35584832-8D94C583-52C4-458B-A860-8739983EB6E7Q35791164-7FF0F56C-4C9B-4B87-BA07-C3035B00C582Q35853204-47A04DF8-FE3C-4CC9-86E2-890A85E77ABDQ35910686-1A61ACA1-1B27-4B0D-9031-7E9ADB3F5F46Q36032639-6DC1D7D5-6FE6-416B-8557-6A29A80D0F95Q36061216-2E153EB4-F6BE-4996-8D10-C6FD0CC06D91Q36095028-DB254657-BC01-4B62-80E5-EDB8EDD9ACDFQ36108849-B950C2A4-9B79-4A0B-856B-00036633D752Q36116891-6D64A9FD-7C37-4B20-8838-AF4BDD4B91ECQ36280919-F43953E2-85D8-4B28-B6A1-CF6D90B2DE34Q36283753-1A8098F9-6A60-4D8D-A34E-F80282367A98Q36296165-EA5EA59D-1FCC-408F-95E6-15BCB9FCE21AQ36309930-037175CF-0051-411B-A47F-30357DD88C25Q36313190-FF516184-CBC3-4F39-9E40-4215F339665E
P2860
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
description
2001 nĆ® lÅ«n-bĆ»n
@nan
2001 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Õ
ÕøÖÕ¶Õ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2001 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÖÕ¶Õ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2001幓ć®č«ę
@ja
2001幓č«ę
@yue
2001幓č«ę
@zh-hant
2001幓č«ę
@zh-hk
2001幓č«ę
@zh-mo
2001幓č«ę
@zh-tw
2001幓č®ŗę
@wuu
name
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
@ast
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
@en
type
label
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
@ast
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
@en
prefLabel
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
@ast
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
@en
P2093
P2860
P921
P1476
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.
@en
P2093
P2860
P304
P356
10.1128/AAC.45.6.1930-1933.2001
P407
P577
2001-06-01T00:00:00Z